- Home
- ISPC vs VRAX Comparison
ISPC vs VRAX Comparison
Compare ISPC & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | VRAX |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ISPC | VRAX |
|---|---|---|
| Price | $0.15 | $0.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 9.3M | 148.8K |
| Earning Date | 04-13-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,291,115.00 | N/A |
| Revenue This Year | $35.93 | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.14 | $0.17 |
| 52 Week High | $2.16 | $1.34 |
Technical Indicators
Market Signals| Indicator | ISPC | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 33.02 | 33.39 |
| Support Level | N/A | N/A |
| Resistance Level | $0.44 | $0.25 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.94 | 12.37 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.